← Open Payments lookup

TINA MCCARTAN: Open Payments

NPI 1114390416 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,340 in 102 payments from 29 companies in 2025. Trend: 2023 $1,412 · 2024 $1,585 · 2025 $2,340

Food & beverage: $2,340
CompanyPaymentsAmount
Novo Nordisk Inc11$457
Lilly USA, LLC11$241
Radius Health, Inc.12$184
Amgen Inc.9$149
BETA BIONICS, INC.4$119
Avvisto Therapeutics, LLC4$116
Insulet Corporation5$103
Neurocrine BioSciences, Inc.3$95
Bayer Healthcare Pharmaceuticals Inc.4$82
Sequel Med Tech, LLC3$81

Products named: Ozempic, Wegovy, Tymlos, MOUNJARO, JARDIANCE, iLet Bionic Pancreas, CYCLOSET, Omnipod.

Industry payments across TX — which companies pay providers there.